These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 74116)

  • 21. Comparative scanning and transmission electron microscopy of the prostatic gland in different species (mouse, rat, dog, man).
    Guggenheim R; Bartsch G; Tannenbaum M; Rohr HP
    Scan Electron Microsc; 1979; (3):721-8. PubMed ID: 93304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The connective tissue framework in the normal prostate, BPH and prostate cancer: analysis by scanning electron microscopy after cellular digestion.
    Morrison C; Thornhill J; Gaffney E
    Urol Res; 2000 Oct; 28(5):304-7. PubMed ID: 11127707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the heterogeneity of R3327 rat prostatic tumors derived from single-cell clones.
    Thompson SA; Johnson MP; Heidger PM; Lubaroff DM
    Prostate; 1985; 6(4):369-87. PubMed ID: 4088951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human benign prostatic hyperplasia: a stromal disease? New perspectives by quantitative morphology.
    Rohr HP; Bartsch G
    Urology; 1980 Dec; 16(6):625-33. PubMed ID: 6160671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of basement membrane to histologic grade of human prostatic carcinoma.
    Fuchs ME; Brawer MK; Rennels MA; Nagle RB
    Mod Pathol; 1989 Mar; 2(2):105-11. PubMed ID: 2657718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.
    Pflug BR; Onoda M; Lynch JH; Djakiew D
    Cancer Res; 1992 Oct; 52(19):5403-6. PubMed ID: 1382843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
    Pathol Biol (Paris); 2014 Jun; 62(3):129-36. PubMed ID: 24745345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate.
    Sahlén GE; Egevad L; Ahlander A; Norlén BJ; Ronquist G; Nilsson BO
    Prostate; 2002 Nov; 53(3):192-9. PubMed ID: 12386919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia.
    Bødker A; Bruun J; Balslev E; Iversen HG; Meyhoff HH; Andersson KE
    Scand J Urol Nephrol; 1999 Aug; 33(4):237-42. PubMed ID: 10515086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia.
    Wu F; Ding S; Li X; Wang H; Liu S; Wu H; Bi D; Ding K; Lu J
    Oncotarget; 2016 Mar; 7(11):12053-62. PubMed ID: 26919249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma.
    Cheville JC; Bostwick DG
    Am J Surg Pathol; 1995 Sep; 19(9):1068-76. PubMed ID: 7544958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
    Bartsch G; Frick J; Rüegg I; Bucher M; Holliger O; Oberholzer M; Rohr HP
    J Urol; 1979 Oct; 122(4):481-6. PubMed ID: 90176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrillar bodies in human prostate.
    Seman G
    Prostate; 1983; 4(2):179-87. PubMed ID: 6188141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal influences on the dog prostate--a correlation study with light microscopy, transmission and scanning electron microscopy.
    Rohr HP; Bartsch G; Tannenbaum M; Neumann N; Guggenheim R
    Scan Electron Microsc; 1979; (3):665-71. PubMed ID: 93303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.
    Schlechte H; Lenk SV; Löning T; Schnorr D; Rudolph BD; Ditscherlein G; Loening SA
    Eur Urol; 1998; 34(5):433-40. PubMed ID: 9803007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA distribution patterns of prostatic tissue obtained at time of transurethral resection.
    Klein FA; Ratliff JE; White FK
    Urology; 1988 Mar; 31(3):260-5. PubMed ID: 2450421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.
    Egan AJ; Lopez-Beltran A; Bostwick DG
    Am J Surg Pathol; 1997 Aug; 21(8):931-5. PubMed ID: 9255256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistochemical study of the prostatic tissues with monoclonal antibody against gamma-seminoprotein. Analyses of benign prostatic hyperplasia, metastatic foci from adenocarcinoma of the prostate and malignant neoplasms other than adenocarcinoma of the prostate].
    Fujino A; Shimura S; Murayama M; Ao T; Yokoyama E; Mashimo S; Ishibashi A; Koshiba K; Kuwao S
    Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):527-34. PubMed ID: 7685842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.